Technology Listing:
Biomarker for Low Risk NTM Infection in the Airway of Cystic Fibrosis Patients - 20-03
Biomarkers to Differentiate Atopic Dermatitis Endotypes - 19-01
Biomarkers Predictive of Atopic Dermatitis Susceptibility - 17-06
TSLP: A Biomarker Predictive of Atopic Dermatitis Development in Infants - 16-06
Gene panel diagnostic test predictive of ARDS severity - 15-04
TAK-1 and MSK-1: biomarkers and targets for corticosteroid-resistant asthma - 13-12
Blood Biomarkers Determine Therapeutic Response in Cystic Fibrosis Patients - 08-22
Adenosine A2A Receptor: A Prognosis Marker for Lung Cancer - 08-11
MAGP-2: An extracellular factor shown to have pro-angiogenic properties - 06-05
New Agar Medium for the Isolation and Testing Susceptibility of Mycobacterium Tuberculosis Against Drugs - 00-05
Therapeutics
View list of available Therapeutics.
Research Tools
View list of available Antibodies or Animal models.
Biomedical Devices
View list of available biomedical devices.
For more information, contact Emmanuel Hilaire at HilaireE@njhealth.org.
